We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Transfecting Small Molecules, Peptides

The Nucleofector® Technology enables efficient and reproducible transfection of primary cells and cell lines at throughputs of up to 96 samples per run.

Nucleofection® now extends its range of application to deliver small molecules substrates and protein substrates such as peptides, proteins and antibodyconjugates.

The Nucleofector 96-well Shuttle® System combines the proven advantages of Nucleofection with the flexible throughput capacity to enable cell-based screening approaches using RNAi or peptide libraries, early ADME-Tox applications using small molecules, or pathway validation using inhibitory peptides or antibodies.

The delivery of small molecules, peptides and antibodies is presented, demonstrating the capabilities of the Nucleofector Technology and its potential to enhance standard applications in pharmaceutical research and drug discovery.